NASDAQ
Cosmo Pharmaceuticals N.V. (CMOPF) has a fcf yield of -0.88% as of Friday, May 29, 2026. This represents a 117.49% decrease compared to its 12-month average of 5.01%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.